Cargando…
Pretreatment of Human Cervicovaginal Mucus with Pluronic F127 Enhances Nanoparticle Penetration without Compromising Mucus Barrier Properties to Herpes Simplex Virus
[Image: see text] Mucosal drug delivery nanotechnologies are limited by the mucus barrier that protects nearly all epithelial surfaces not covered with skin. Most polymeric nanoparticles, including polystyrene nanoparticles (PS), strongly adhere to mucus, thereby limiting penetration and facilitatin...
Autores principales: | Ensign, Laura M., Lai, Samuel K., Wang, Ying-Ying, Yang, Ming, Mert, Olcay, Hanes, Justin, Cone, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261994/ https://www.ncbi.nlm.nih.gov/pubmed/25347518 http://dx.doi.org/10.1021/bm501419z |
Ejemplares similares
-
The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis
por: Hoang, Thuy, et al.
Publicado: (2020) -
The Cervicovaginal Mucus Barrier
por: Lacroix, Guillaume, et al.
Publicado: (2020) -
IgG in cervicovaginal mucus traps HSV and prevents vaginal Herpes infections
por: Wang, Ying-Ying, et al.
Publicado: (2014) -
Cervicovaginal mucus barrier properties during pregnancy are impacted by the vaginal microbiome
por: Zierden, Hannah C., et al.
Publicado: (2023) -
Altering Mucus Rheology to “Solidify” Human Mucus at the Nanoscale
por: Lai, Samuel K., et al.
Publicado: (2009)